Erratum: Limited evidence of human papillomavirus on breast tissue using molecular in situ methods (Cancer DOI: 10.1002/cncr.26389);Limited evidence of human papillomavirus on breast tissue using molecular in situ methods

Cancer

Volumn 118, Issue 5, 2012, Pages 1212-1220

  Baltzell, Kimberly ^a   Buehring, Gertrude C ^b   Krishnamurthy, Savitri ^c   Kuerer, Henry ^c   Shen, Hua Min ^b   Sison, Jennette D ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarkers; breast cancer; human papillomavirus; in situ hybridization; polymerase chain reaction

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL TYPE; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN SITU POLYMERASE CHAIN REACTION; MAJOR CLINICAL STUDY; MOLECULAR PROBE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR VIRUS; UNITED STATES; VIRUS CAPSID; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

EID: 84857264876     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26530     Document Type: Erratum

References (30)

1. Choi YL, Cho EY, Kim JH, et al. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 2007; 28: 327-332. (Pubitemid 351567550)
2. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO,. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004; 84: 131-137. (Pubitemid 38393363)
3. de Leon DC, Montiel DP, Nemcova J, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients [serial online]. BMC Cancer. 2009; 9: 26.
4. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE,. Presence of papillomavirus sequences in condylomatous lesions of the mammillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005; 7: R1-R11.
5. Di Lonardo A, Venuti A, Marcante ML,. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992; 21: 95-100.
6. Gumus M, Yumuk PF, Salepci T, et al. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res. 2006; 25: 515-521. (Pubitemid 46166765)
7. Heng B, Glenn WK, Ye Y, et al. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009; 101: 1345-1350.
8. Hennig EM, Di Lonardo A, Venuti A, Holm R, Marcante ML, Nesland JM,. HPV 16 in multiple neoplastic lesions in women with CIN III. J Exp Clin Cancer Res. 1999; 18: 369-377.
9. Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ,. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer. 2005; 93: 946-948. (Pubitemid 41487022)
10. Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008; 99: 408-414.
11. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES,. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem. 2006; 39: 727-731. (Pubitemid 44036781)
12. Li T, Lu ZM, Guo M, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002; 95: 2571-2576. (Pubitemid 35424044)
13. Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol. 2001; 4: 329-334. (Pubitemid 34693880)
14. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC,. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2005; 75: 276-281.
15. Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C,. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004; 31: 292-297. (Pubitemid 39371063)
16. Yu Y, Morimoto T, Sasa M, et al. HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res. 1999; 19 (6B): 5057-5061. (Pubitemid 30103323)
17. Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer. 2000; 7: 33-36.
18. Nuovo GJ,. The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol. 2007; 38: 1123-1136. (Pubitemid 47058170)
19. Patillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF,. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science. 1997; 196: 1456-1458.
20. Nuovo GJ,. PCR in Situ Hybridization: Protocols and Applications. Philadelphia, PA: Lippincott-Raven; 1996.
21. Fontaine V, Mascaux C, Weyn C, et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol. 2007; 45: 928-934. (Pubitemid 46427713)
22. Fitzgibbons PL, Henson DE, Hutter RV,. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998; 122: 1053-1055. (Pubitemid 29009396)
23. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M,. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat. 2011; 126: 515-520.
24. Bratthauer GL, Tavassoli FA, O'Leary TJ,. Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992; 188: 384-386.
25. Schiffman M, Castle PE,. The promise of global cervical-cancer prevention. N Engl J Med. 2005; 353: 2101-2104. (Pubitemid 41653100)
26. Gopalkrishna V, Singh UR, Sodhani P, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996; 39: 197-202. (Pubitemid 26283203)
27. Howley PM, Lowy DR,. Papillomaviruses and their replication. In:, Knipe DM, Howley PM, eds. Fields Virology. Fifth ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
28. Chu TY, Shen SY, Lee HS, Liu HS,. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer. 1999; 24: 127-134.
29. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953; 6: 963-968.
30. Heaphy CM, Griffith JK, Bisoffi M,. Molecular field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat. 2009; 118: 229-239.